# LONGEVITY SURVIVOR

Comparative-biology research lane for JANUS Lapis.

## Frozen question

What functional architecture repeatedly appears in organisms that show exceptional longevity, negligible senescence, unusually preserved function, or repeated rejuvenation?

This lane does **not** assume that a single gene, telomerase, slow metabolism, regeneration, or any animal mechanism is sufficient for human life extension.

## Current survivor model

```text
PREVENT EXCESS DAMAGE
        ↓
DETECT DAMAGE
        ↓
REPAIR WHAT IS REPAIRABLE
        ↓
CLEAR DAMAGED PROTEINS / ORGANELLES
        ↓
REMOVE IRREPARABLE OR DANGEROUS CELLS
        ↓
REPLACE REQUIRED CELLS
        ↓
VERIFY CELL IDENTITY + TISSUE ARCHITECTURE
        ↓
SUPPRESS MALIGNANT ESCAPE
        ↓
RESTORE SYSTEMIC HOMEOSTASIS
        ↺
```

Conceptual condition:

```text
DAMAGE_RATE < EFFECTIVE_MAINTENANCE_CAPACITY
AND
CANCER_ESCAPE remains controlled
```

## Expanded gates

1. Damage-rate control
2. Genome repair and chromatin stability
3. Controlled telomere / replicative capacity
4. Proteostasis, autophagy and organelle quality control
5. Irreparable-cell removal
6. Correct-cell replacement
7. Cancer suppression
8. Epigenetic identity preservation or safe reset
9. Tissue and systemic homeostasis

## Reverse → HUMAN

The human pass changes the question from **what regeneration machinery is missing?** to **which permission states allow a specific tissue to renew while preserving identity, geometry and tumour suppression?**

```text
HUMANS_HAVE_MOST_COMPONENT_CLASSES = SUPPORTED
ONE_GLOBAL_REGENERATION_SWITCH      = NOT_SUPPORTED
SAFE_RENEWAL                        = PERMISSION + CONTROL + STOP
```

The strongest within-human control is the contrast between tissues that share the same genome but have very different regenerative behavior. This produces an emergent cross-cutting gate:

```text
SPATIOTEMPORAL_ORCHESTRATION_AND_TERMINATION
```

A renewal program must be local, temporary, lineage-preserving, damage-aware, spatially instructed, cancer-surveilled and reliably terminable.

## Lock-aligned cross-tissue pass — v2.1

The developmental pass aligns HEART / COCHLEA / SPINAL CORD / SKIN / TENDON by the **relative loss of regenerative capacity** rather than by chronological age:

```text
BEFORE_LOCK → LOCK_TRANSITION → AFTER_LOCK
       tau<0       tau≈0            tau>0
```

### P0-A — RESIDENT_REGENERATIVE_COMPETENCE_COLLAPSE

Strong independent support: heart, cochlea, tendon; supportive parallels: spinal cord and skin.

### P0-B — TEMPORARY_WOUND_STATE / RESOLUTION

Strong support: spinal cord, skin, tendon; supportive cardiac parallel.

### P0-C — NICHE_MECHANICAL_MATURATION

Heart and skin provide strong causal support. A third clean developmental native-mechanics perturbation is still required before promotion.

## Resolution-gate kinetic killer test — v2.2

The half-life hypothesis was tested directly against published time courses. The simple rule

```text
REGENERATION = SHORT WOUND STATE
SCAR         = SAME STATE PERSISTS
```

**does not survive as a universal rule.**

### What survives

- **Neonatal spinal cord:** Fn1-high microglial bridge state is present at ~3 dpi, absent in the reported 5 dpi in-situ time point, fibronectin bridge is gone by ~7 dpi, and microglia return toward homeostasis within the first week. Adult lesions retain activated macrophage/microglial states and scar architecture much longer.
- **Neonatal tendon:** alpha-SMA+ helper cells are abundant early and strongly reduced by d14; scar-associated transcripts return toward control by d28 while intrinsic tenocyte recruitment builds neo-tendon.
- **Acomys ear skin:** myofibroblasts are transient during regeneration, and experimentally prolonging their persistence by YAP-TEAD inhibition shifts healing toward fibrosis.

### What kills the half-life-only model

- **Adult heart:** alpha-SMA myofibroblasts are themselves transient and largely lose alpha-SMA by ~10–14 days, yet the scar persists because fibroblasts transition into alternate scar-maintaining states and ECM matures.
- **Acomys full-thickness skin (29 July 2026):** dermal alpha-SMA+ wound-bed cells clear earlier than in Mus, but a separate alpha-SMA+ bridge at the panniculus carnosus persists for weeks while muscle regenerates successfully.

Therefore persistence time alone is not the invariant.

### Revised P0 survivor

```text
WOUND_STATE_FATE_ROUTING_AND_RESOLUTION_GATE
=
ENTRY
→ WOUND STATE
→ SPATIAL ROUTING
→ HANDOFF TO REBUILD
→ TERMINATE PROFIBROTIC OUTPUT
→ CLEAR / REDIFFERENTIATE / REDIRECT / FATE-SWITCH
→ RESTORE ARCHITECTURE
```

The key variable is **where the wound-state goes**, not merely how long one marker remains positive.

Required measurements now include:

1. duration;
2. spatial compartment;
3. cell-state identity;
4. lineage fate after marker loss;
5. ECM reversibility and crosslinking;
6. duration of profibrotic output;
7. handoff to resident regenerative cells;
8. final tissue architecture.

## Current falsification state

```text
TELOMERASE_ALONE                    = REFUTED_AS_SUFFICIENT
LOW_METABOLISM_ALONE                = REFUTED_AS_SUFFICIENT
DNA_REPAIR_ALONE                    = REFUTED_AS_SUFFICIENT
SINGLE_MASTER_GENE                  = NOT_SUPPORTED
ALL_SIX_AXES_SYNC_GLOBALLY          = REFUTED
HALF_LIFE_ONLY_RESOLUTION_RULE      = REFUTED
SCAR_EQUALS_SAME_ALPHA_SMA_STATE    = REFUTED
MULTI_GATE_ARCHITECTURE             = SURVIVES
WOUND_STATE_FATE_ROUTING            = CURRENT_P0_REVISED_SURVIVOR
DIRECT_HUMAN_TRANSLATION            = NOT_ESTABLISHED
```

## Canonical artifacts

- [`LONGEVITY-SURVIVOR-TRANCEPTION-2026-08-23-v1.0.json`](LONGEVITY-SURVIVOR-TRANCEPTION-2026-08-23-v1.0.json)
- [`TELOMERASE-CANCER-TRADEOFF-TRANCEPTION-2026-08-23-v1.0.json`](TELOMERASE-CANCER-TRADEOFF-TRANCEPTION-2026-08-23-v1.0.json)
- [`HUMAN-SAFE-RENEWAL-FULL-JANUS-COUNCIL-2026-08-23-v1.0.json`](HUMAN-SAFE-RENEWAL-FULL-JANUS-COUNCIL-2026-08-23-v1.0.json)
- [`HUMAN-TISSUE-RENEWAL-PERMISSION-MATRIX-2026-08-23-v1.0.json`](HUMAN-TISSUE-RENEWAL-PERMISSION-MATRIX-2026-08-23-v1.0.json)
- [`DEVELOPMENTAL-PERMISSION-MATRIX-LONGEVITY-SURVIVOR-2026-08-23-v2.0.json`](DEVELOPMENTAL-PERMISSION-MATRIX-LONGEVITY-SURVIVOR-2026-08-23-v2.0.json)
- [`LOCK-ALIGNED-OVERLAY-LONGEVITY-SURVIVOR-2026-08-23-v2.1.json`](LOCK-ALIGNED-OVERLAY-LONGEVITY-SURVIVOR-2026-08-23-v2.1.json)
- [`RESOLUTION-GATE-KINETIC-KILLER-TEST-2026-08-23-v2.2.json`](RESOLUTION-GATE-KINETIC-KILLER-TEST-2026-08-23-v2.2.json)
- [`SCIENTIFIC-OUTREACH-QUEUE-RESOLUTION-GATE-2026-08-23-v1.0.json`](SCIENTIFIC-OUTREACH-QUEUE-RESOLUTION-GATE-2026-08-23-v1.0.json)

## Scientific-sharing boundary

The current result is suitable to share as a **cross-tissue hypothesis note and quantitative-data request**, not as a new experimental discovery or universal regeneration mechanism. The strongest outreach questions concern raw time-series state occupancy, lineage fate after marker loss, spatial compartment identity and ECM-state persistence.

## Next gates

- reconstruct normalized state-occupancy curves from source data rather than infer universal half-lives from sparse time points;
- track what cells become after marker loss: apoptosis, redifferentiation, migration, spatial redirection or alternate stable scar state;
- measure profibrotic **output half-life** (periostin, collagen production, crosslinking, stiffness, MMP/TIMP balance) separately from alpha-SMA marker lifetime;
- seek a third clean causal native-tissue test for the ECM/mechanical maturation lock;
- preserve **marker loss != cell clearance**, **cell clearance != ECM clearance**, **animal regeneration != human therapy**.

## Boundary

This branch is an exploratory hypothesis-ranking and comparative-biology lane. It is not a medical protocol, treatment recommendation, gene-editing guide, self-experimentation guide, or claim that human lifespan extension has been achieved.
